Open AccessErratum to: High SARS-CoV-2 seroprevalence but no severe course of COVID-19 disease among people on opioid agonist treatment in Zurich: a cross-sectional study
Author(s) -
Swiss Medical Weekly
Publication year - 2022
Publication title -
schweizerische medizinische wochenschrift
Language(s) - English
Resource type - Journals
ISSN - 0036-7672
DOI - 10.4414/smw.2022.w30149
Subject(s) - medicine , covid-19 , seroprevalence , cross sectional study , disease , agonist , virology , betacoronavirus , infectious disease (medical specialty) , immunology , outbreak , antibody , receptor , pathology , serology